BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15798002)

  • 1. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.
    Fang X; Hu S; Watanabe T; Weintraub NL; Snyder GD; Yao J; Liu Y; Shyy JY; Hammock BD; Spector AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):260-70. PubMed ID: 15798002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
    Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
    Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
    Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
    Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.
    Fang X; Weintraub NL; McCaw RB; Hu S; Harmon SD; Rice JB; Hammock BD; Spector AA
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2412-20. PubMed ID: 15284062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.
    Ng VY; Morisseau C; Falck JR; Hammock BD; Kroetz DL
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2462-8. PubMed ID: 16917105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
    Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
    Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
    Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.
    Watanabe T; Morisseau C; Newman JW; Hammock BD
    Drug Metab Dispos; 2003 Jul; 31(7):846-53. PubMed ID: 12814960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.
    Wu HF; Yen HJ; Huang CC; Lee YC; Wu SZ; Lee TS; Lin HC
    J Biomed Sci; 2015 Oct; 22():94. PubMed ID: 26494028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epoxide hydrolase: a new target for cardioprotection.
    Gross GJ; Nithipatikom K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells.
    Kim HS; Kim SK; Kang KW
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model.
    Jiang JX; Guan Y; Shen HJ; Jia YL; Shen J; Zhang LH; Liu Q; Zhu YL; Xie QM
    Eur J Pharmacol; 2020 Feb; 868():172874. PubMed ID: 31866410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.
    Morin C; Sirois M; Echavé V; Albadine R; Rousseau E
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):564-75. PubMed ID: 20008283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.
    Liu Y; Zhang Y; Schmelzer K; Lee TS; Fang X; Zhu Y; Spector AA; Gill S; Morisseau C; Hammock BD; Shyy JY
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16747-52. PubMed ID: 16267130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.
    Kim IH; Nishi K; Tsai HJ; Bradford T; Koda Y; Watanabe T; Morisseau C; Blanchfield J; Toth I; Hammock BD
    Bioorg Med Chem; 2007 Jan; 15(1):312-23. PubMed ID: 17046265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.